We serve Chemical Name:4-(2-(trichlorosilyl)ethyl)pyridine CAS:17082-70-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(2-(trichlorosilyl)ethyl)pyridine
CAS.NO:17082-70-1
Synonyms:EINECS 241-138-3;trichloro-(2-pyridin-4-yl-ethyl)-silane;Pyridine, 4-(2-(trichlorosilyl)ethyl)-;4-[2-(Trichlorosilyl)ethyl]pyridine;4-(2-Trichlorsilylethyl)-pyridin;4-(2-(trichlorosilyl)ethyl)pyridine;Pyridine, 4-[2-(trichlorosilyl)ethyl]-
Molecular Formula:C7H8Cl3NSi
Molecular Weight:240.590
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:273.4±23.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.529
PSA:12.89000
Exact Mass:238.949158
LogP:4.89
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2985
Packing Group:
Contact us for information like EINECS 241-138-3 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridine, 4-[2-(trichlorosilyl)ethyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[2-(Trichlorosilyl)ethyl]pyridine Use and application,4-[2-(Trichlorosilyl)ethyl]pyridine technical grade,usp/ep/jp grade.
Related News: The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. 4-(2-(trichlorosilyl)ethyl)pyridine manufacturer After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. 4-(2-(trichlorosilyl)ethyl)pyridine supplier The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. 4-(2-(trichlorosilyl)ethyl)pyridine vendor After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. 4-(2-(trichlorosilyl)ethyl)pyridine factory The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.
